Interview: Barry Joyce – Managing Director, VWR Ireland
Barry Joyce, MD at VWR Ireland, takes us through the priorities of the first few months of his appointment, the strategic position of VWR in Ireland and within the global…
VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is the leading, global, independent provider of products, services and solutions to laboratory and production facilities.
With sales in excess of $4.3 billion in 2015, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers’ productivity from research to production. VWR’s differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 9,300 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.
VWR helps accelerate scientific innovation by providing educators, scientists, researchers, medical professionals and engineers the most effective and efficient solutions – products, equipment and services.
Contact
Orion Business Campus, Northwest Business Park, Ballycoolin, Blanchardstown, Dublin 15, Ireland
Tel: +353 01 88 22 222
Website: https://ie.vwr.com/store/
Email: sales.ie@vwr.com
To read the interview with VWR Ireland’s Barry Joyce, click here
Barry Joyce, MD at VWR Ireland, takes us through the priorities of the first few months of his appointment, the strategic position of VWR in Ireland and within the global…
Mr. Somers, can you please introduce us to the Helsinn Group and its unique in-licensing model? Helsinn is a Swiss-based, private company owned by the Braglia family. The Braglias have…
Mr. Martin, you were appointed as Genzyme’s GM for UK and Ireland last month after having spent a decade at the organization. Robin Kenselaar, Head of Genzyme EMEA, noted that…
Ms. Dickens, in our interview with your Sanofi colleague Jan Hendrix in Belgium last month, he commented that it is amazing how diversified this company has become in just the…
Can you give us a sense of the history of this company and its Irish roots? The company started life in the UK and has always been a GI franchise…
Mr. Hanlon, can you please begin by introducing Clonmel Healthcare to our readers? Clonmel Healthcare was founded by an Irish family in the 1970’s. During this time, its primary goal…
Mr. Hynds, you were personally instrumental in leading the establishment of Actavis in Ireland in 2008. You commented at the time, ‘Historically, Actavis grew by acquisition in other markets, but…
Mr. Looney, what has it been like to run this business for 26 years? Looking back, what can you say that you have built? It has certainly been an exciting…
Dr. Coveney, what motivated you to start this company? I had been working for the multinationals for a number of years—Schering Plough, and a number of other organizations. In 1999,…
In 2008, MSD began building a human vaccine facility in Carlow—a 220MN EUR investment that the company expanded upon last year with an additional 7Mn EUR. What is the importance…
This interview also features the comments of Geraldine Murphy, Managing Director of Leo Pharma, Ireland. Ms. Murphy, your transition to your current position was precipitated by a major refocusing that…
This interview also features the comments of Brendan Fitzpatrick, Vice President Finished Goods Manufacturing. Ms. Murphy, your transition to your current position was precipitated by a major refocusing that LEO…
Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.” More recently, Time Magazine put Taoiseach Enda Kenny…
See our Cookie Privacy Policy Here
